Charles B Haaser's Net Worth

$10.8 Thousand

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is Charles B Haaser?

Charles B Haaser does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include YIELD10 BIOSCIENCE, INC., and ABIOMED INC.

SEC CIK

Charles B Haaser's CIK is 0001230903

Past Insider Trading and Trends

2021 was Charles B Haaser's most active year for acquiring shares with 4 total transactions. Charles B Haaser's most active month to acquire stocks was the month of January. 2006 was Charles B Haaser's most active year for disposing of shares, totalling 4 transactions. Charles B Haaser's most active month to dispose stocks was the month of January. 2005 saw Charles B Haaser paying a total of $322,200.00 for 32,500 shares, this is the most they've acquired in one year. In 2006 Charles B Haaser cashed out on 13,000 shares for a total of $103,181.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

YIELD10 BIOSCIENCE, INC. (YTEN) Snapshot price: $1.6

VP Finance and CAO

Charles B Haaser owns 5,949 units of Common Stock which is worth $9,518.40. From 2014 to 2024 Charles B Haaser acquired a total of 321,651 shares in YIELD10 BIOSCIENCE, INC. at a cost of $92,797.75, Charles also disposed a total of 12,267 shares of YIELD10 BIOSCIENCE, INC. equalling to $54,703.28.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-10.94%
-731.00
$1.50
-$1,096.50
5.95K
Aug 15
Form 4
+970.69%
100K
$0.30
$30,000.00
110.3K
Feb 15
Form 4
-8.68%
-979.00
$3.59
-$3,514.61
10.3K
Feb 10
Form 4
—
0
—
—
0
Jan 12
Form 4
-6.79%
-822.00
$2.68
-$2,202.96
11.28K
Aug 10
Form 4
-2.74%
-341.00
$4.25
-$1,449.25
12.1K
Mar 1
Form 4
+81.93%
5.6K
$3.83
$21,459.49
12.44K
Feb 10
Form 4
+54.07%
2.4K
$4.20
$10,079.76
6.84K
Dec 3
Form 4
—
0
—
—
0
Sep 28
Form 4
-6.05%
-286.00
$6.71
-$1,919.06
4.44K
Sep 1
Form 4
+70.27%
1.95K
$16.03
$31,258.50
4.72K
Mar 1
Form 4
-19.98%
-693.00
$22.77
-$15,779.61
2.77K
Feb 11
Form 4
-19.98%
-693.00
$22.77
-$15,779.61
2.77K
Feb 11
Form 4
—
0
—
—
0
Jan 25
Form 4
-14.48%
-587.00
$6.55
-$3,844.85
3.47K
Aug 11
Form 4
—
0
—
—
0
May 28
Form 4
+7,272.73%
4K
—
—
4.05K
Feb 11
Form 4
—
0
—
—
0
May 22
Form 4
-9.72%
-245.00
$1.16
-$284.20
2.28K
Apr 1
Form 4
—
0
—
—
0
May 23
Form 4
-8.75%
-2.67K
$0.37
-$989.01
27.89K
Apr 1
Form 4
—
0
—
—
0
Oct 26
Form 4
-12.12%
-4.22K
$1.86
-$7,843.62
30.57K
Apr 1
Form 4
+20,769.80%
207.7K
—
—
208.7K
Apr 1
Form 4
—
0
—
—
0
Nov 10
Form 3
—
0
—
—
0
No matching records found

ABIOMED INC No price found

Principal Accounting Officer

Charles B Haaser owns 2,379 units of Common Stock, $.01 par value.acquired a total of 6,500 shares in ABIOMED INC at a cost of $31,885.00, Charles also disposed a total of 6,500 shares of ABIOMED INC equalling to $71,296.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$9.24
-$12,381.00
2.38K
May 31
Form 4
—
0
$7.55
-$27,030.00
2.38K
Feb 8
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Mar 1
Form 4/A
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Nov 2 - Jul 1
Form 4
—
0
—
—
0
No matching records found